initially O O O O
licensed O O O O
in O O O O
2006, O O O O
aimed O O O O
at O O O O
preventing O O O O
high-risk O O O O
strains O O O O
of O O O O
HPV, O O O O
strains O O O O
that O O O O
can O O O O
cause O O O O
cancer O O O O
or O O O O
genital O O O O
warts. O O O O
For O O O O
a O O O O
[variety O O O O
of O O O O
reasons](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716467/), O O O O
uptake O O O O
of O O O O
HPV O O O O
vaccines O O O O
remains O O O O
low O O O O
in O O O O
the O O O O
United O O O O
States. O O O O
Several O O O O
states O O O O
have O O O O
undertaken O O O O
efforts O O O O
to O O O O
improve O O O O
uptake, O O O O
using O O O O
a O O O O
variety O O O O
of O O O O
policy O O O O
mechanisms, O O O O
to O O O O
improve O O O O
uptake. O O O O
In Reason 1 O O
response, Reason 1 O O
several Reason 1 O O
persons Reason 1 O O
or Reason 1 O O
group, Reason 1 O O
many Reason 1 O O
of Reason 1 O O
which Reason 1 O O
(though Reason 1 O O
not Reason 1 O O
all) Reason 1 O O
can Reason 1 O O
be Reason 1 O O
fairly Reason 1 O O
described Reason 1 O O
as Reason 1 O O
anti-vaccine, Reason 1 O O
have Reason 1 O O
made Reason 1 O O
a Reason 1 O O
series Reason 1 O O
of Reason 1 O O
claims Reason 1 O O
about Reason 1 O O
HPV Reason 1 O O
vaccines, Reason 1 O O
claiming Reason 1 O O
the Reason 1 O O
efforts Reason 1 O O
were Reason 1 O O
unjustified Reason 1 O O
on Reason 1 O O
policy Reason 1 O O
grounds Reason 1 O O
and Reason 1 O O
the Reason 1 O O
vaccines Reason 1 O O
unsafe Reason 1 O O
and/or Reason 1 O O
unnecessary. Reason 1 O O
This O O O O
post O O O O
addresses O O O O
those O O O O
claims O O O O
with O O O O
referenced, O O O O
science-based O O O O
information, O O O O
explaining O O O O
why O O O O
the O O O O
policy O O O O
efforts O O O O
to O O O O
improve O O O O
HPV O O O O
uptake O O O O
are O O O O
well-founded, O O O O
and O O O O
the O O O O
arguments O O O O
against O O O O
them O O O O
either O O O O
inaccurate O O O O
or O O O O
unconvincing. O O O O
Importance O O O O
and O O O O
Effectiveness: O O O O
HPV O O O O
infections O O O O
are O O O O
very O O O O
common, O O O O
and O O O O
cause O O O O
substantial O O O O
harms O O O O
and O O O O
deaths. O O O O
Increasing Reason 4 O O
vaccine Reason 4 O O
uptake Reason 4 O O
can Reason 4 O O
reduce Reason 4 O O
those Reason 4 O O
harms, Reason 4 O O
and Reason 4 O O
is Reason 4 O O
a Reason 4 O O
legitimate, Reason 4 O O
well-justified Reason 4 O O
public Reason 4 O O
health Reason 4 O O
goal. Reason 4 O O
- O O O O
HPV O O O O
infections O O O O
cause O O O O
tens O O O O
of O O O O
thousands O O O O
of O O O O
cancers O O O O
and O O O O
thousands O O O O
of O O O O
deaths O O O O
each O O O O
year. O O O O
HPV O O O O
vaccines O O O O
can O O O O
prevent O O O O
the O O O O
vast O O O O
majority O O O O
of O O O O
that O O O O
cancer. O O O O
The O O O O
lifetime O O O O
risk O O O O
for O O O O
women O O O O
for O O O O
one O O O O
of O O O O
these O O O O
cancers O O O O
- O O O O
cervical O O O O
cancer O O O O
alone O O O O
- O O O O
is O O O O
[1:161](https://www.cancer.org/cancer/cancer-basics/lifetime-probability-of-developing-or-dying-from-cancer.html). O O O O
Low O O O O
uptake, O O O O
therefore, O O O O
which O O O O
leaves O O O O
a O O O O
risk O O O O
of O O O O
many O O O O
cancers O O O O
and O O O O
deaths, O O O O
can O O O O
fairly O O O O
be O O O O
described O O O O
as O O O O
[a O O O O
public O O O O
health O O O O
crisis](https://www.cdc.gov/cancer/HPV/statistics/index.htm). O O O O
- O O O O
Most O O O O
HPV O O O O
cases O O O O
clear O O O O
on O O O O
their O O O O
own, O O O O
but O O O O
those O O O O
that O O O O
do O O O O
not O O O O
can O O O O
[lead O O O O
to O O O O
cancer O O O O
or O O O O
death](https://www.cdc.gov/std/HPV/stdfact-HPV.htm). O O O O
- O O O O
There Reason 4 O O
is Reason 4 O O
increasing Reason 4 O O
evidence Reason 4 O O
that Reason 4 O O
the Reason 4 O O
vaccine Reason 4 O O
reduces Reason 4 O O
HPV Reason 4 O O
infections Reason 4 O O
with Reason 4 O O
cancer-causing Reason 4 O O
strains. Reason 4 O O
The O O O O
evidence O O O O
comes O O O O
from O O O O
studies O O O O
in O O O O
the O O O O
[United](http://pediatrics.aappublications.org/content/early/2016/02/19/peds.2015-1968) O O O O
[States](https://www.ncbi.nlm.nih.gov/pubmed/26123561), O O O O
in O O O O
[ O O O O
Australia](https://www.ncbi.nlm.nih.gov/pubmed/23087430), O O O O
and O O O O
in O O O O
[Scotland](https://wwwnc.cdc.gov/eid/article/22/1/15-0736_article). O O O O
While O O O O
it O O O O
is O O O O
too O O O O
early O O O O
to O O O O
see O O O O
the O O O O
effect O O O O
on O O O O
cancer O O O O
rates O O O O
just O O O O
yet, O O O O
the O O O O
reduction O O O O
in O O O O
infection, O O O O
and O O O O
dramatic O O O O
reductions O O O O
in O O O O
precancerous O O O O
lesions, O O O O
are O O O O
strong O O O O
evidence O O O O
that O O O O
the O O O O
vaccine O O O O
is O O O O
[working O O O O
as O O O O
expected](http://www.kegel.com/HPV/faq/#effectiveness-pap). O O O O
In O O O O
other O O O O
words, O O O O
if O O O O
a O O O O
person O O O O
isn't O O O O
infected, O O O O
they O O O O
cannot O O O O
develop O O O O
precancerous O O O O
lesions; O O O O
preventing O O O O
precancerous O O O O
lesions O O O O
means O O O O
the O O O O
vaccinated O O O O
person O O O O
doesn't O O O O
go O O O O
on O O O O
to O O O O
develop O O O O
cancer. O O O O
- O O O O
The Reason 5 O O
vaccine Reason 5 O O
has Reason 5 O O
been Reason 5 O O
shown Reason 5 O O
to Reason 5 O O
be Reason 5 O O
safe Reason 5 O O
even Reason 5 O O
for Reason 5 O O
people Reason 5 O O
who Reason 5 O O
are Reason 5 O O
infected Reason 5 O O
with Reason 5 O O
the Reason 5 O O
HPV Reason 5 O O
vaccine Reason 5 O O
at Reason 5 O O
the Reason 5 O O
time Reason 5 O O
of Reason 5 O O
vaccination. Reason 5 O O
However, Reason 1 O O
some Reason 1 O O
people Reason 1 O O
who Reason 1 O O
are Reason 1 O O
opposed Reason 1 O O
to Reason 1 O O
the Reason 1 O O
HPV Reason 1 O O
vaccine Reason 1 O O
claim Reason 1 O O
such Reason 1 O O
people Reason 1 O O
have Reason 1 O O
a Reason 1 O O
higher Reason 1 O O
risk Reason 1 O O
of Reason 1 O O
developing Reason 1 O O
cancer, Reason 1 O O
citing Reason 1 O O
the Reason 1 O O
outcomes Reason 1 O O
for Reason 1 O O
one Reason 1 O O
subgroup Reason 1 O O
in Reason 1 O O
one Reason 1 O O
clinical Reason 1 O O
trial. Reason 1 O O
This O O O O
fear O O O O
was O O O O
addressed O O O O
at O O O O
the O O O O
May O O O O
2006 O O O O
meeting O O O O
of O O O O
the O O O O
FDA O O ScientificAuthority O
body O O O O
that O O O O
oversees O O O O
the O O O O
safety O O O O
of O O O O
vaccines, O O O O
the O O O O
Vaccines O O O O
and O O O O
Related O O O O
Biological O O O O
Products O O O O
Advisory O O O O
Committee. O O O O
To Reason O O O
paraphrase Reason O O O
the Reason O O O
[report](http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4222B3.pdf) Reason O O O
prepared Reason O O O
for Reason O O O
the Reason O O O
meeting Reason O O O
the Reason O O O
subgroup Reason O O O
that Reason O O O
showed Reason O O O
a Reason O O O
higher Reason O O O
risk Reason O O O
in Reason O O O
the Reason O O O
pre-2006 Reason O O O
trials Reason O O O
had Reason O O O
other Reason O O O
enhanced Reason O O O
risk Reason O O O
factor Reason O O O
developing Reason O O O
cancers, Reason O O O
compared Reason O O O
to Reason O O O
the Reason O O O
subjects Reason O O O
who Reason O O O
received Reason O O O
placebo. Reason O O O
Other O O O O
subgroups O O O O
in O O O O
the O O O O
study O O O O
did O O O O
not O O O O
have O O O O
larger O O O O
numbers O O O O
of O O O O
subgroups O O O O
that O O O O
developed O O O O
cervical O O O O
disease. O O O O
A Reason 4 O O
later, Reason 4 O O
larger Reason 4 O O
study Reason 4 O O
of Reason 4 O O
over Reason 4 O O
17,000 Reason 4 O O
women Reason 4 O O
showed Reason 4 O O
that Reason 4 O O
women Reason 4 O O
receiving Reason 4 O O
the Reason 4 O O
HPV Reason 4 O O
vaccine Reason 4 O O
after Reason 4 O O
being Reason 4 O O
infected Reason 4 O O
with Reason 4 O O
HPV Reason 4 O O
[did Reason 4 O O
not Reason 4 O O
have Reason 4 O O
a Reason 4 O O
higher Reason 4 O O
risk](http://www.ncbi.nlm.nih.gov/pubmed/20139221) Reason 4 O O
of Reason 4 O O
developing Reason 4 O O
cancer. Reason 4 O O
- O O O O
The Reason 4 O O
vaccine Reason 4 O O
does Reason 4 O O
not Reason 4 O O
increase Reason 4 O O
the Reason 4 O O
risk Reason 4 O O
for Reason 4 O O
later Reason 4 O O
cervical Reason 4 O O
disease. Reason 4 O O
Some Reason 2 O O
anti-vaccine Reason 2 O O
activists Reason 2 O O
claim Reason 2 O O
that Reason 2 O O
"girls Reason 2 O O
who Reason 2 O O
received Reason 2 O O
the Reason 2 O O
four Reason 2 O O
strain Reason 2 O O
HPV Reason 2 O O
shot, Reason 2 O O
when Reason 2 O O
assessed Reason 2 O O
10 Reason 2 O O
years Reason 2 O O
later, Reason 2 O O
were Reason 2 O O
actually Reason 2 O O
more Reason 2 O O
likely Reason 2 O O
to Reason 2 O O
be Reason 2 O O
infected Reason 2 O O
with Reason 2 O O
high Reason 2 O O
risk, Reason 2 O O
low Reason 2 O O
risk, Reason 2 O O
and Reason 2 O O
all Reason 2 O O
strains Reason 2 O O
of Reason 2 O O
HPV. Reason 2 O O
The O O O O
four O O O O
vaccine O O O O
strains O O O O
were O O O O
reduced- O O O O
but O O O O
other, O O O O
possibly O O O O
more O O O O
pathogenic, O O O O
HPV O O O O
viruses O O O O
moved O O O O
in O O O O
to O O O O
fill O O O O
the O O O O
void.". O O O O
This O O O O
is O O O O
the O O O O
"replacement O O O O
risk" O O O O
argument. O O O O
This O O O O
claim O O O O
cites O O O O
a O O O O
2015 O O O O
poster O O O O
presentation, O O O O
which O O O O
was O O O O
later O O O O
published O O O O
in O O O O
[Human O O O O
Vaccines O O O O
& O O O O
Immunotherapeutic](http://www.tandfonline.com/doi/abs/10.1080/21645515.2015.1066948?journalCode=khvi20#.V3PX5bgrKUk)s. O O O O
The O O O O
published O O O O
article O O O O
actually O O O O
says O O O O
the O O O O
difference O O O O
between O O O O
vaccinated O O O O
and O O O O
non-vaccinated O O O O
women O O O O
was O O O O
much O O O O
reduced O O O O
after O O O O
adjusting O O O O
for O O O O
sexual O O O O
behavior O O O O
variables, O O O O
and O O O O
that O O O O
women O O O O
who O O O O
were O O O O
vaccinated O O O O
early O O O O
with O O O O
the O O O O
four-serotype O O O O
vaccine O O O O
may O O O O
benefit O O O O
from O O O O
the O O O O
newer, O O O O
nine-serotype O O O O
vaccine. O O O O
Further, O O O O
later O O O O
studies O O O O
[did O O O O
not O O O O
](http://www.kegel.com/HPV/faq/#replacement)find O O O O
[ O O O O
type O O O O
replacement](http://www.jahonline.org/article/S1054-139X(16)30452-9/abstract). O O O O
In O O O O
short, O O O O
the O O O O
"replacement O O O O
risk" O O O O
phenomenon O O O O
alleged O O O O
is O O O O
not O O O O
borne O O O O
out O O O O
by O O O O
current O O O O
research. O O O O
Safety: Reason 5 O O
The Reason 5 O O
data Reason 5 O O
showing Reason 5 O O
HPV Reason 5 O O
vaccines Reason 5 O O
safe Reason 5 O O
is Reason 5 O O
abundant. Reason 5 O O
A O O O O
[recent O O O O
review O O O O
](https://link.springer.com/article/10.1007/s40264-017-0625-z)found O O O O
that O O O O
with O O O O
studies O O O O
in O O O O
over O O O O
2 O O O O
million O O O O
people, O O O O
and O O O O
data O O O O
from O O O O
70 O O O O
countries, O O O O
no O O O O
real O O O O
safety O O O O
concerns O O O O
were O O O O
found O O O O
related O O O O
to O O O O
HPV O O O O
vaccines. O O O O
If O O O O
readers O O O O
would O O O O
like O O O O
a O O O O
complete O O O O
list O O O O
of O O O O
HPV O O O O
vaccine O O O O
safety O O O O
studies, O O O O
[this O O O O
site O O O O
](http://www.kegel.com/HPV/safety/)summarizes O O O O
the O O O O
safety O O O O
data O O O O
on O O O O
HPV O O O O
vaccines O O O O
with O O O O
links O O O O
to O O O O
the O O O O
studies O O O O
Addressing O O O O
Common O O O O
Themes O O O O
Repeated O O O O
by O O O O
Opponents O O O O
of O O O O
the O O O O
HPV O O O O
Vaccine O O O O
to O O O O
Challenge O O O O
this O O O O
Data: O O O O
Complaints O O O O
About O O O O
"No O O O O
True O O O O
Placebo O O O O
Testing" O O O O
and O O O O
the O O O O
Types O O O O
Of O O O O
Placebo O O O O
Used O O O O
in O O O O
Trial O O O O
- O O O O
Several Reason 2 O O
anti-vaccine Reason 2 O O
activists Reason 2 O O
are Reason 2 O O
troubled Reason 2 O O
by Reason 2 O O
the Reason 2 O O
fact Reason 2 O O
that Reason 2 O O
the Reason 2 O O
control Reason 2 O O
used Reason 2 O O
in Reason 2 O O
the Reason 2 O O
trials Reason 2 O O
for Reason 2 O O
Gardasil Reason 2 O O
was Reason 2 O O
a Reason 2 O O
solution Reason 2 O O
containing Reason 2 O O
the Reason 2 O O
other Reason 2 O O
vaccine Reason 2 O O
ingredients, Reason 2 O O
including Reason 2 O O
AAHS, Reason 2 O O
an Reason 2 O O
aluminum Reason 2 O O
salt Reason 2 O O
adjuvant Reason 2 O O
used Reason 2 O O
for Reason 2 O O
decades Reason 2 O O
in Reason 2 O O
infant Reason 2 O O
vaccines Reason 2 O O
like Reason 2 O O
hepatitis Reason 2 O O
B Reason 2 O O
and Reason 2 O O
others. Reason 2 O O
These O O O O
issues O O O O
were O O O O
specifically O O O O
addressed O O O O
by O O O O
a O O O O
vaccinologist O O O O
in O O O O
[a O O O O
recent O O O O
article](https://sciblogs.co.nz/diplomaticimmunity/2018/02/21/the-brouhaha-around-placebo-choice-in-vaccine-trials/), O O O O
which O O O O
is O O O O
quoted O O O O
here O O O O
at O O O O
some O O O O
length: O O O O
"The O O O O
placebo O O O O
effect O O O O
The O O O O
key O O O O
objective O O O O
of O O O O
a O O O O
placebo O O O O
is O O O O
to O O O O
allow O O O O
the O O O O
participant O O O O
to O O O O
believe O O O O
they O O O O
have O O O O
received O O O O
the O O O O
medicine O O O O
being O O O O
tested. O O O O
In O O O O
the O O O O
case O O O O
of O O O O
an O O O O
injectable O O O O
vaccine O O O O
the O O O O
most O O O O
common O O O O
reaction O O O O
is O O O O
injection O O O O
site O O O O
pain, O O O O
sometimes O O O O
with O O O O
minor O O O O
redness O O O O
and O O O O
swelling. O O O O
Often, O O O O
the O O O O
added O O O O
adjuvant O O O O
(immune O O O O
enhancer) O O O O
can O O O O
be O O O O
the O O O O
main O O O O
cause O O O O
of O O O O
the O O O O
reaction O O O O
and O O O O
it O O O O
is O O O O
just O O O O
doing O O O O
its O O O O
job. O O O O
From O O O O
a O O O O
vaccinology O O O O
perspective O O O O
a O O O O
mild O O O O
to O O O O
moderate O O O O
injection O O O O
site O O O O
reaction O O O O
is O O O O
generally O O O O
a O O O O
good O O O O
thing. O O O O
.... O O O O
The O O O O
role O O O O
of O O O O
the O O O O
antigen O O O O
Another O O O O
factor O O O O
in O O O O
placebo O O O O
selection O O O O
is O O O O
the O O O O
importance O O O O
of O O O O
understanding O O O O
the O O O O
role O O O O
of O O O O
the O O O O
active O O O O
ingredient O O O O
(antigen O O O O
or O O O O
antibody O O O O
generator) O O O O
